| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accurate analysis of race/ethnicity and socioeconomic status
|
Fingrut, Warren B.
|
|
|
8 |
20 |
p. 5433-5434
|
article
|
| 2 |
Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy
|
Hoff, Fieke W.
|
|
|
8 |
20 |
p. 5297-5305
|
article
|
| 3 |
Biomarker-derived fast-and-frugal decision tree for preemption of veno-occlusive disease/sinusoidal obstructive syndrome
|
Paczesny, Sophie
|
|
|
8 |
20 |
p. 5426-5429
|
article
|
| 4 |
CARs to the rescue: rare aggressive lymphoma gets a power up
|
Kamdar, Manali
|
|
|
8 |
20 |
p. 5342-5343
|
article
|
| 5 |
CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma
|
Pophali, Priyanka A.
|
|
|
8 |
20 |
p. 5290-5296
|
article
|
| 6 |
Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera
|
Sørensen, Anders Lindholm
|
|
|
8 |
20 |
p. 5416-5425
|
article
|
| 7 |
COVID-19 vaccination during therapy in relation to COVID-19 death in CLL
|
Brown, Jennifer R.
|
|
|
8 |
20 |
p. 5262-5265
|
article
|
| 8 |
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations
|
Mehta, Rohtesh S.
|
|
|
8 |
20 |
p. 5306-5314
|
article
|
| 9 |
Hasselbalch HC, Kristiansen MH, Kjær L, et al. CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidities. Blood Adv. 2024;8(3):681-682.
|
|
|
|
8 |
20 |
p. 5344
|
article
|
| 10 |
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
|
Epperla, Narendranath
|
|
|
8 |
20 |
p. 5355-5364
|
article
|
| 11 |
Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department
|
Siewny, Lauren
|
|
|
8 |
20 |
p. 5330-5338
|
article
|
| 12 |
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies
|
Bettazova, Nardjas
|
|
|
8 |
20 |
p. 5279-5289
|
article
|
| 13 |
Inhibition of MICA and MICB shedding enhances memory-like NK-cell–mediated cytotoxicity against multiple myeloma
|
Tahri, Sabrin
|
|
|
8 |
20 |
p. 5365-5370
|
article
|
| 14 |
Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT
|
Mehta, Rohtesh S.
|
|
|
8 |
20 |
p. 5438-5449
|
article
|
| 15 |
Jerkeman M, Kolstad A, Hutchings M, et al. MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood Adv. 2024;8(2):407-415.
|
|
|
|
8 |
20 |
p. 5345
|
article
|
| 16 |
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry
|
Asiimwe, Innocent G.
|
|
|
8 |
20 |
p. 5248-5261
|
article
|
| 17 |
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
|
Matsumura, Itaru
|
|
|
8 |
20 |
p. 5237-5247
|
article
|
| 18 |
Nutritional intervention as adjuvant therapy for T-cell acute lymphoblastic leukemia
|
Garcia, Miriam B.
|
|
|
8 |
20 |
p. 5266-5267
|
article
|
| 19 |
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel
|
Ahmed, Nausheen
|
|
|
8 |
20 |
p. 5346-5354
|
article
|
| 20 |
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy
|
Camus, Vincent
|
|
|
8 |
20 |
p. 5371-5381
|
article
|
| 21 |
Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function
|
Le Luduec, Jean-Benoît
|
|
|
8 |
20 |
p. 5382-5399
|
article
|
| 22 |
Proactive systematic hemophilia carrier screening: a step toward gender equity in hemophilia care
|
Krumb, Evelien
|
|
|
8 |
20 |
p. 5268-5278
|
article
|
| 23 |
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation
|
Landspersky, Theresa
|
|
|
8 |
20 |
p. 5400-5414
|
article
|
| 24 |
Tarlock K, Gerbing RB, Ries RE, et al. Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood Adv. 2024;8(9):2094-2103.
|
|
|
|
8 |
20 |
p. 5415
|
article
|
| 25 |
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia
|
Jankovic, Maja
|
|
|
8 |
20 |
p. 5315-5329
|
article
|
| 26 |
Too short or unnecessarily long: walking the fine line
|
Sainatham, Chiranjeevi
|
|
|
8 |
20 |
p. 5430-5432
|
article
|
| 27 |
Tyrosine kinase inhibitor for CML: all the same?
|
Veltmaat, Lukas
|
|
|
8 |
20 |
p. 5339-5341
|
article
|
| 28 |
What makes a good Samaritan: age, HLA matching, or both?
|
Crivello, Pietro
|
|
|
8 |
20 |
p. 5435-5437
|
article
|
Journal description